A randomised non-comparative phase II study of atezolizumab, bevacizumab and chemotherapy in EGFR-mutant NSCLC with acquired resistance – The ETOP 15-19 ABC-lung trial

Authors: Soo, R.A. ^a, Vervita, K. ^b, Früh, M. ^{c, d}, Cho, B.C. ^e, Majem, M. ^{f, g}, Rodriguez Abreu, D. ^{h, g}, Ribi, K. ⁱ, Callejo, A. ^{g, j}, Moran, T. ^{g, k}, Domine Gomez, M. ^{l, g}, Provencio, M. ^{g, m}, Addeo, A. ⁿ, Han, J.Y. ^o, Ortega Granados, A.L. ^{p, g}, Reck, M. ^q, Blasco, A. ^{r, g}, Garcia Campelo, R. ^{s, g}, Sala González, M.A. ^{t, g}, Britschgi, C. ^u, Roschitzki-Voser, H. ⁱ, Ruepp, B. ⁱ, Gasca-Ruchti, A. ⁱ, Haberecker, M. ^v, Dafni, U. ^{d, w}, Peters, S. ^x, Stahel, R.A. ^{i, ⁎}

Source: In Lung Cancer April 2025 202

Immune checkpoint blockers in solid organ transplant recipients and cancer: the INNOVATED cohort

Authors: Remon, J., Auclin, E., Zubiri, L., Schneider, S., Rodriguez-Abreu, D., Minatta, N., Gautschi, O., Aboubakar, F., Muñoz-Couselo, E., Pierret, T., Rothschild, S.I., Cortiula, F., Reynolds, K.L., Thibault, C., Gavralidis, A., Blais, N., Barlesi, F., Planchard, D., Besse, B.M.D.

Source: In ESMO Open May 2024 9(5)

Overall survival and central nervous system activity of crizotinib in ROS1-rearranged lung cancer—final results of the EUCROSS trial

Authors: Michels, S., Massutí, B., Vasyliv, I., Stratmann, J., Frank, J., Adams, A., Felip, E., Grohé, C., Rodriguez-Abreu, D., Bischoff, H., Carcereny i Costa, E., Corral, J., Pereira, E., Fassunke, J., Fischer, R.N., Insa, A., Koleczko, S., Nogova, L., Reck, M., Reutter, T., Riedel, R., Schaufler, D., Scheffler, M., Weisthoff, M., Provencio, M., Merkelbach-Bruse, S., Hellmich, M., Sebastian, M., Büttner, R., Persigehl, T., Rosell, R., Wolf, J.

Source: In ESMO Open February 2024 9(2)

Pemetrexed plus platinum with or without pembrolizumab in patients with previously untreated metastatic nonsquamous NSCLC: protocol-specified final analysis from KEYNOTE-189

Authors: Rodríguez-Abreu, D., Powell, S.F., Hochmair, M.J., Gadgeel, S., Esteban, E., Felip, E., Speranza, G., De Angelis, F., Dómine, M., Cheng, S.Y., Bischoff, H.G., Peled, N., Reck, M., Hui, R., Garon, E.B., Boyer, M., Kurata, T., Yang, J., Pietanza, M.C., Souza, F., Garassino, M.C.

Source: In Annals of Oncology July 2021 32(7):881-895

Malignant pleural mesothelioma: Treatment patterns and outcomes from the Spanish Lung Cancer Group

Authors: Remon, J., Nadal, E., Dómine, M., Ruffinelli, J., García, Y., Pardo, J.C., López, R., Cilleruelo, A., García-Campelo, R., Martín, P., Juan, O., González-Larriba, J.L., Provencio, M., Olmedo, E., Ponce, S., Cumplido, D., Barenys, C., Majem, M., Massutti, B., Rodriguez-Abreu, D., Porta, R., Sala, M.A., Martinez-Kareaga, M., Lianes, P., Reguart, N. ^*

Source: In Lung Cancer September 2020 147:83-90

SEOM clinical guideline for the management of immune-related adverse events in patients treated with immune checkpoint inhibitors (2019)

Authors: Majem, M., García-Martínez, E., Martinez, M., Muñoz-Couselo, E., Rodriguez-Abreu, D., Alvarez, R., Arance, A., Berrocal, A., de la Cruz-Merino, L., Lopez-Martin, J. A.

Source: Clinical & translational oncology. 22(2):213-222

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100164053633.0x000001&indx=1&recIds=ETOCvdc_100164053633.0x000001

64O Lenvatinib plus pembrolizumab, pemetrexed, and a platinum (len + pembro + chemo) as first-line therapy for metastatic non squamous non-small cell lung cancer (NSCLC): Phase III LEAP-006 study

Authors: Herbst, R.S., Cho, B.C., Zhou, C., Burotto, M., Cobo Dols, M., Sendur, M.A.N., Moiseyenko, V., Zurawski, B., Casarini, I.A., Nishio, M., Hui, R., Pons-Tostivint, E., Dudnik, J., Ahmed, S., Okpara, C.E., Yin, L., Luo, Y., Bhagwati, N., Rodriguez Abreu, D.

Source: In Immuno-Oncology and Technology December 2023 20 Supplement

EP.06G.20 Advanced Squamous Cell Lung Carcinoma in Never Smokers: A Different Entity? Analysis from the Thoracic Tumor Registry in Spain (RTT)

Authors: Blanco, M., Collazo-Lorduy, A., Cobo, M., Calvo, V., Martínez- Cutillas, M., Cantero, A., Rodríguez-Abreu, D., Carcereny, E., Bosch-Barrera, J., García Campelo, M.R., López Castro, R., Bernabé, R., del Barco, E., Ortega, A.L., Sánchez, A., Aparisi-Aparisi, F., Vázquez, S., Guirado, M., Casal, J., Medina, K., Cerezo, S., Camps, C., Gonzalez-Larriba, J.L., Sala, M.A., Massutí, B., Dómine, M., Losada, B., Royuela, A., Provencio, M.

Source: In Journal of Thoracic Oncology October 2024 19(10) Supplement:S521-S521

EP.13D.09 Characteristics and Survival in Never-Smoking Small Cell Lung Cancer Cases an Analysis from the Thoracic Tumor Registry

Authors: Candal-Pedreira, C., Ruano-Ravina, A., Calvo de Juan, V., Cobo, M., Trigo, J.M., Rodríguez-Abreu, D., Estival, A., Carcereny, E., Cucurull, M., López Castro, R., Medina, A., García Campelo, R., Cordeiro González, P., Sánchez-Gastaldo, A., Bosch-Barrera, J., Massutí, B., Dómine, M., Camps, C., Ortega, A.L., Provencio, M.

Source: In Journal of Thoracic Oncology October 2024 19(10) Supplement:S678-S678

EP.01A.05 Analysis of Diagnostic Delay and Its Impact on Survival in Lung Cancer Cases. Results from the Spanish Thoracic Tumor Registry

Authors: Candal-Pedreira, C., Ruano-Ravina, A., Calvo de Juan, V., Cobo, M., Trigo, J.M., Rodríguez-Abreu, D., Estival, A., Carcereny, E., Cucurull, M., López Castro, R., Medina, A., García Campelo, R., Cordeiro González, P., Sánchez-Gastaldo, A., Bosch-Barrera, J., Massutí, B., Dómine, M., Camps, C., Ortega, A.L., Provencio, M.

Source: In Journal of Thoracic Oncology October 2024 19(10) Supplement:S429-S430

P3.08E.01 Perioperative Chemoimmunotherapy Rescue Cold HLA-Deficient Tumors Inducing Strong Immune Responses and Long-Term Survival

Authors: Molina-Alejandre, M., Perea, F., Calvo, V., Nadal, E., Huidobro, G., Martínez, C., Martínez-Martí, A., Sierra, B., Insa, A., Massutí, B., Aguilar, A., Barneto, I., Rodríguez - Abreu, D., De Castro Carpeño, J., García Campelo, M.R., Cobo, M., Wistuba, I., Parra, E.R., Martín-López, J., Megías, D., Muñoz-Viana, R., Casarrubios, M., Garrido, F., Aptsiauri, N., Ruiz-Cabello, F., Provencio, M., Cruz- Bermúdez, A.

Source: In Journal of Thoracic Oncology October 2024 19(10) Supplement:S335-S336

MA01.08 Five-Year Clinical Outcomes of Perioperative Nivolumab and Chemotherapy in Stage III Non-Small-Cell Lung Cancer (NADIM Trial)

Authors: Provencio, M., Nadal, E., Insa, A., Campelo, M.R. García, Calvo, V., Palmero, R., Lázaro, M., Dómine, M., Majem, M., Rodríguez - Abreu, D., Martínez-Martí, A., De Castro Carpeño, J., Cobo, M., Bernabé, R., Viñolas, N., Barneto, I., Viteri, S., Cruz-Bermúdez, A., Romero, A., Massutí, B.

Source: In Journal of Thoracic Oncology October 2024 19(10) Supplement:S54-S55

OA12.05 APOLO: Phase II Trial of Induction Chemo-Immunotherapy Plus Chemoradiotherapy and Maintenance Immunotherapy in Stage III NSCLC

Authors: Provencio, M., Campos, B., Guirado, M., Vilà, L., Campelo, M.R. García, Dorta, M., Vázquez Estévez, S., Ferrández, A., Sala, M.A., Ortega, A.L., Blasco, A., Insa, A., Areses, M.C., Sullivan, I., López Castro, R., Calvo, V., Rodríguez - Abreu, D., Bosch-Barrera, J., López-Martín, A., Marsé, R., Torrado, L., Matskov, K., Giner, J., Fernández Bruno, M., Sánchez Saugar, E., Martínez-Toledo, C., Cruz-Bermudez, A.

Source: In Journal of Thoracic Oncology October 2024 19(10) Supplement:S37-S37

SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2015

Authors: García-Campelo, R., Bernabé, R., Cobo, M., Corral, J., Coves, J., Dómine, M., Nadal, E., Rodriguez-Abreu, D., Viñolas, N., Massuti, B.

Source: CLINICAL AND TRANSLATIONAL ONCOLOGY. 17(12):1020-1029

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN374042979&indx=1&recIds=ETOCRN374042979

SEOM clinical guidelines for the treatment of follicular non-Hodgkin’s lymphoma

Authors: Provencio Pulla, M., Alfaro Lizaso, J., de la Cruz Merino, L., Gumá i Padró, J., Quero Blanco, C., Gómez Codina, J., Llanos Muñoz, M., Martinez Banaclocha, N., Rodriguez Abreu, D., Rueda Domínguez, A.

Source: CLINICAL AND TRANSLATIONAL ONCOLOGY. 17(12):1014-1019

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN374042929&indx=1&recIds=ETOCRN374042929

SEOM clinical guidelines for the treatment of Hodgkin’s lymphoma

Authors: Rueda Domínguez, A., Alfaro Lizaso, J., Cruz Merino, L., Gumá i Padró, J., Quero Blanco, C., Gómez Codina, J., Llanos Muñoz, M., Martinez Banaclocha, N., Rodriguez Abreu, D., Provencio Pulla, M.

Source: CLINICAL AND TRANSLATIONAL ONCOLOGY. 17(12):1005-1013

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN374042887&indx=1&recIds=ETOCRN374042887

Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer.

Authors: Wakelee, H.¹, hwakelee@stanford.edu, Liberman, M.², Kato, T.³, Tsuboi, M.⁴, Lee, S.-H.⁵, Gao, S.⁶, Chen, K.-N.⁷, Dooms, C.⁸, Majem, M.⁹, Eigendorff, E.¹⁰, Martinengo, G. L.¹¹, Bylicki, O.¹², Rodriguez-Abreu, D.¹³, Chaft, J. E.¹⁴, Novello, S.¹⁵, Yang, J.¹⁶, Keller, S. M.¹⁶, Samkart, A.¹⁶, Spicer, J. D.¹⁷

Source: New England Journal of Medicine; 8/10/2023, Vol. 389 Issue 6, p491-503, 13p

1311P Phase II, open-label study of frontline tusamitamab ravtansine with pembrolizumab ± chemotherapy in advanced non-squamous non-small cell lung cancer: Updated results from CARMEN-LC05 trial

Authors: Rodriguez Abreu, D., Veillon, R., Ravoire, M., Gonzalez-Larriba, J.L., Orlandi, F.J., Nagy, T., Paz-Ares, L.G., Huang, C.H., Roubec, J., Isambert, N., García Campelo, M.R., Matias, D.D.A., Ray, F., Celedon, P., Onn, A., Shamai, S., Carcereny, E., Charbonnier, L., Soufflet, C., Esteban González, E.

Source: In Annals of Oncology September 2024 35 Supplement 2:S834-S834

1284P Clinical utility of liquid biopsy for non-small cell lung cancer patients with ALK fusion variants treated with brigatinib

Authors: Robado de Lope, L., García Campelo, M.R., Azkárate Martínez, A., Cobo Dols, M., Calvo de Juan, V., Nadal, E., Rodriguez Abreu, D., Callejo Perez, A., Dómine Gómez, M., Juan Vidal, O.J., Collazo Lorduy, A., Mosquera Martinez, J., Marse Fabregat, R., Mediavilla Medel, P., Serna-Blasco, R., Romero, A., Provencio Pulla, M.

Source: In Annals of Oncology September 2024 35 Supplement 2:S819-S819

1054P CRUCIAL: Analysis of the incidence of second primary cancers in the Spanish thoracic tumor registry according to treatment

Authors: Provencio Pulla, M., Cobo Dols, M., Rodriguez Abreu, D., Carcereny, E., López Castro, R., García Campelo, M.R., Bernabe Caro, R., Bosch-Barrera, J., Massuti Sureda, B., Sanchez Hernandez, A., Ortega Granados, A.L.O., Guirado, M., Barco Morillo, E. del, Camps, C.J., Casal Rubio, J., Dómine Gómez, M., Sala Gonzalez, M.A., Medina Sanchez, K., Gonzalez-Larriba, J.L., Suay Montagud, G.

Source: In Annals of Oncology September 2024 35 Supplement 2:S702-S702